Analyst Upgrades: Apple Inc., Chesapeake Energy Corporation, and Ocular Therapeutix Inc

Analysts upwardly revised their ratings and price targets on tech giant Apple Inc. (NASDAQ:AAPL), natural gas company Chesapeake Energy Corporation (NYSE:CHK), and biotech stock Ocular Therapeutix Inc (NASDAQ:OCUL)

Aug 11, 2016 at 10:18 AM
facebook X logo linkedin

Analysts are weighing in on tech stock Apple Inc. (NASDAQ:AAPL), oil-and-gas company Chesapeake Energy Corporation (NYSE:CHK), and biotech Ocular Therapeutix Inc (NASDAQ:OCUL). Here's a quick roundup of today's bullish brokerage notes on AAPL, CHK, and OCUL.

  • AAPL is up 0.4% at $108.45, following a price-target increase to $117 from $115 at RBC. The brokerage firm said it was raising its iPhone units outlook for the company's fiscal first quarter, explaining the extra week could boost sales an additional 5-6 million units. On the charts, Apple Inc. has been making progress in recent weeks, but still has its downtrending 320-day moving average sitting right overhead. What's more, AAPL's 14-day Relative Strength Index (RSI) has struck 70, meaning it's technically been overbought, and could be due for a breather. 

  • CHK has picked up 2% at $4.89, after the company announced it would be selling its Barnett Shale assets to private firm Saddle Barnett Resources. What's more, Chesapeake Energy Corporation said it has renegotiated its pipeline agreement with Williams Partners LP (NYSE:WPZ). Together, the two moves could save the company roughly $1.9 billion. This has grabbed the attention of analysts, with Goldman Sachs, UBS, and KLR all raising their price targets, with the latter setting its mark at $9 -- territory not explored since last October. Meanwhile, short-term options traders might be cheering, too, since CHK's Schaeffer's put/call open interest ratio (SOIR) of 0.81 is just 1 percentage point from a 12-month low -- signaling a very unusual call-skew.

  • OCUL is rallying this morning, after JMP Securities initiated coverage with a "market outperform" rating and a bold $21 price target. Not only is this more than triple the stock's current perch at $6.44, but it reflects major confidence in a stock that's down 64% year-over-year. Today, the shares are up 10%, and short sellers are certainly on notice as a result. Specifically, 12.9% of Ocular Therapeutix Inc's float is sold short, which equals a week's worth of buying power, going by average daily volumes. 
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI